LTR Pharma (ASX:LTP) has announced that it has achieved its latest regulatory milestone for SPONTAN with the successful completion of extractables testing and the launch of its leachables studies. …
Latest Video
New Stories
-
Tetratherix lists on the ASX following successful IPO
June 30, 2025 - - Australian Biotech -
LTR Pharma achieves key FDA milestone through extractables study
June 30, 2025 - - Australian Biotech -
Arovella Therapeutics announces the retirement of non-executive chair
June 30, 2025 - - Australian Biotech -
The focus on system and patient productivity is a new 'open door' opportunity
June 29, 2025 - - Latest News -
Incoming brief advises minister to dampen expectations on HTA Review
June 29, 2025 - - Latest News -
Incoming brief recommends doing more and reviewing less
June 28, 2025 - - Latest News -
The Dispatched 'Week in Review' Podcast - 27 June
June 27, 2025 - - Podcast